Insurers: vaccinated get infected with Covid 3 times more often

Kaiser Permanente (KP), a well-known insurance company and
healthcare provider, has commissioned a study to evaluate the
effectiveness of the COVID-19 mRNA vaccine against the
dominant omicron subvariants.
The KP study (https://bit.ly/3Vv94Oe) revealed that those who are
triple-vaccinated are more likely to be infected with COVID-19.
Shockingly, or maybe not, they were also more likely to suffer
severe illness and die from coronavirus.
According to a report (https://bit.ly/3T6G65Q) by investigative
journalist Daniel Horowitz, one chart on page 30 of the KP preprint
study found that vaccine efficacy against the omicron subvariants
dropped significantly 14 to 30 days after vaccination.
The efficacy continues to fall in the following months until
it reaches negative territory after five months. This suggests that
the recipients are more likely to get coronavirus than the
unvaccinated.
Additionally, the study results indicate that triple-vaccinated
individuals are at greater risk of getting COVID-19 after five
months than those who only received two vaccine doses.
Horowitz, who has reported on the negative efficacy of the
coronavirus vaccine for the past year, added that it's possible that
the vaccines "prime the body to respond with a version of the virus
that has long since changed, thereby making the natural immune
response misfire."
Those who support COVID-19 vaccine mandates claim that this is
the reason for the new bivalent shot for the BA.5 omicron variant
that was approved after it was studied in only eight mice and no
human volunteers, said Horowitz. But since a new variant is surging,
the new shot is as irrelevant as the previous ones and may even be
counterproductive.
The Centers for Disease Control and Prevention (CDC) reported that
the new BA.4.6 variant now accounts for at least 13 percent of all
COVID-19 cases and is rising sharply. Other variants also continue
to spread.
Dr. Meryl Nass, an epidemiologist and internal physician, featured
Horowitz's article on her Substack page. Nass wondered if the KP
study was conducted because the company was worried
(https://bit.ly/3S6aVX3) about the excess illness it was seeing.
She said Kaiser "might be willing to do a little truth-telling" as
the company tries to determine "who is going to pay for this
unexpected hit, which presumably did not stop in 2021 but
continues apace."

You are viewing proxied material from gopher.erb.pw. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.